October 2024 - Cancer Currents Blog
-
Combination Chemo Helps People with Leiomyosarcoma Live Longer
Results from a French clinical trial have identified what experts say should now be the recommended initial treatment of advanced leiomyosarcoma. In the trial, the combination of trabectedin (Yondelis) and doxorubicin improved survival by a median of 9 months.